ERCC5 and breast cancer: We genotyped or surveyed available genetic data of our candidate variants: NTHL1 c.244C>T; p.Gln82Ter, EXO1 c.1268-1G>T, FANCC c.897G>T; p.Arg299Ser, ERCC5 c.2556A>G; p.Ile852Met and NEIL1 c.248G>T; p.Gly83Asp in different FC OC and BC study groups and population-matched controls, regardless of their carrier status for BRCA1 and BRCA2 PVs (Figure 1B and Table S1).